Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Experimental Cell Research

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-4827(02)00040-XPMID 12651161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heregulin-dependent Activation of Phosphoinositide 3-Kinase and Akt via the ErbB2/ErbB3 Co-receptor*

  2001cited by this paper
• Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Phosphorylation and regulation of Raf by Akt (protein kinase B).

  1999cited by this paper
• Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

  1999cited by this paper
• Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

  1999cited by this paper
• Interaction of the p23/p198 protein with ErbB-3.

  1999cited by this paper
• Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression*

  1999cited by this paper
• NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

  1999cited by this paper
• Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor

  1999cited by this paper
• The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.

  1999cited by this paper
• Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis

  1998cited by this paper
• Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.

  1998cited by this paper
• ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

  1998cited by this paper
• Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

  1998cited by this paper
• Mutation of a Shc Binding Site Tyrosine Residue in ErbB3/HER3 Blocks Heregulin-dependent Activation of Mitogen-activated Protein Kinase*

  1998cited by this paper
• Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation

  1998cited by this paper
• Specificity within the EGF family/ErbB receptor family signaling network

  1998cited by this paper
• p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes.

  1998cited by this paper
• Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.

  1998cited by this paper
• Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3*

  1998cited by this paper
• Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

  1998cited by this paper
• Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase*

  1998cited by this paper
• ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner

  1998cited by this paper
• The akt kinase: molecular determinants of oncogenicity.

  1998cited by this paper
• Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.

  1998cited by this paper
• Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes

  1997cited by this paper
• Signalling through the lipid products of phosphoinositide-3-OH kinase

  1997cited by this paper
• Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt

  1997cited by this paper
• Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

  1997cited by this paper
• Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation

  1997cited by this paper
• Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase.

  1997cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper
• A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain

  1997cited by this paper
• Conditional Inhibition of the Mitogen-activated Protein Kinase Cascade by Wortmannin

  1997cited by this paper
• Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase

  1996cited by this paper
• Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

  1996cited by this paper
• Phosphatidylinositol-3′ Kinase Is Not Required for Mitogenesis or Internalization of the Flt3/Flk2 Receptor Tyrosine Kinase*

  1996cited by this paper
• Neuregulins in development.

  1996cited by this paper
• The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells*

  1996cited by this paper
• Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.

  1996cited by this paper
• Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations*

  1996cited by this paper
• Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway*

  1996cited by this paper
• Functional Roles of the Shc Phosphotyrosine Binding and Src Homology 2 Domains in Insulin and Epidermal Growth Factor Signaling*

  1996cited by this paper
• Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2 (*)

  1996cited by this paper
• Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain

  1995cited by this paper
• Activation and Nuclear Translocation of Mitogen-activated Protein Kinases by Polyomavirus Middle-T or Serum Depend on Phosphatidylinositol 3-Kinase (*)

  1995cited by this paper
• Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.

  1995cited by this paper
• Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.

  1995cited by this paper
• Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase.

  1995cited by this paper
• Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3(*)

  1995cited by this paper
• Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.

  1995cited by this paper
• Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.

  1995cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.

  1995cited by this paper
• PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine.

  1995cited by this paper
• The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus.

  1994cited by this paper
• Role of PI 3-kinase in mitogenesis.

  1994cited by this paper
• ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

  1994cited by this paper
• Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera.

  1994cited by this paper
• Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

  1994cited by this paper
• Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils.

  1994cited by this paper
• Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

  1994cited by this paper
• Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.

  1994cited by this paper
• Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor

  1994cited by this paper
• MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network.

  1994cited by this paper
• Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells.

  1994cited by this paper
• Involvement of pp60c-src with two major signaling pathways in human breast cancer.

  1994cited by this paper
• Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

  1993cited by this paper
• Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.

  1993cited by this paper
• Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

  1993cited by this paper
• Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

  1993cited by this paper
• Cell‐type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER‐2 suggests complex ligand‐receptor relationships.

  1993cited by this paper
• The mitogen-activated protein kinase signal transduction pathway.

  1993cited by this paper
• Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes.

  1992cited by this paper
• Preparation and use of anti-phosphotyrosine antibodies to study structure and function of insulin receptor.

  1991cited by this paper
• Mutants of polyomavirus middle-T antigen.

  1987cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper

• Development and performance evaluations of an HER-2 kit.

  2023cites this paper
• NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes

  2022cites this paper
• MiR-200b Suppresses Gastric Cancer Cell Migration and Invasion by Inhibiting NRG1 through ERBB2/ERBB3 Signaling

  2021cites this paper
• 1 Ligand-Independent EGFR Activation by Anchorage 2 Stimulated Src Promotes Cancer Cell Proliferation 3 and Cetuximab Resistance via ErbB 3 Phosphorylation 4

  2019cites this paper
• Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation

  2019cites this paper
• miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling

  2018cites this paper
• NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?

  2017cites this paper
• Lead exposure and plasma mRNA expression in ERBB2 gene.

  2017cites this paper
• Transcriptome analysis suggests a role for the differential expression of cerebral aquaporins and the MAPK signalling pathway in human temporal lobe epilepsy

  2017cites this paper
• Neuregulin1 alpha activates migration of neuronal progenitors expressing ErbB4.

  2016cites this paper
• Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer

  2016cites this paper
• FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.

  2016cites this paper
• Increased expression of MyD88 and association with paclitaxel resistance in breast cancer

  2016cites this paper
• The EGFR/ERBB Receptor Family

  2015cites this paper
• The Role of Sphingosine Kinase 1 in HER2/Neu-Induced Breast Tumorigenesis

  2015cites this paper
• PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

  2015cites this paper
• Loss Is Associated with Worse Outcome in HER 2-Ampli fi ed Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

  2015cites this paper
• The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways*

  2015cites this paper
• Coarse-Grained Molecular Simulation of Epidermal Growth Factor Receptor Protein Tyrosine Kinase Multi-Site Self-Phosphorylation

  2014cites this paper
• Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

  2014cites this paper
• Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein

  2014cites this paper
• JAB1 NEGATIVELY REGULATES PTEN AND PROMOTES RESISTANCE TO TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER

  2014cites this paper
• Therapeutics , Targets , and Chemical Biology RG 7116 , a Therapeutic Antibody That Binds the Inactive HER 3 Receptor and Is Optimized for Immune Effector Activation

  2013cites this paper
• Precis : As a central integrator of the EGF family receptor system in cancer , HER 3 offers an appealing therapeutic target in many types of human cancer

  2013cites this paper
• RG7116, a therapeutic antibody that binds the inactive HER3 receptor and is optimized for immune effector activation.

  2013cites this paper
• A functional comparison between the HER2high/HER3 and the HER2low/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells

  2012cites this paper
• Gastrointestinal Peptides: Gastrin, Cholecystokinin, Somatostatin, and Ghrelin

  2012cites this paper
• Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis

  2011cites this paper
• Endothelial Jarid2/Jumonji Is Required for Normal Cardiac Development and Proper Notch1 Expression*

  2011cites this paper
• Breast cancer progression is modulated by inherited genetic variance in multiple independent cohorts

  2010cites this paper
• Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte‐derived heregulin

  2010cites this paper
• Role of PTEN in the Tumor Microenvironment

  2009cites this paper
• The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma.

  2009cites this paper
• Heregulin-beta1 promotes metastasis of breast cancer cell line SKBR3 through upregulation of Snail and induction of epithelial-mesenchymal transition.

  2009cites this paper
• Effect of butyrate on the heregulin/ErbB-mediated proliferation of human colorectal cancer cells.

  2009cites this paper
• Development of Immunotherapy Against Prostate Cancer Using Lentivirally-transduced Dendritic Cells Expressing Murine erbB2 as a Model Tumor-associated Antigen

  2008influential citation
• The ERBB3 receptor in cancer and cancer gene therapy

  2008cites this paper
• Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.

  2008cites this paper
• Heregulin β 1 promotes breast cancer cell proliferation through Rac / ERK-dependent induction of cyclin D 1 and p 21 Cip 1

  2008cites this paper
• HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells

  2008cites this paper
• Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration*

  2007cites this paper
• The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

  2007cites this paper
• Growth Stimulation of Non–Small Cell Lung Cancer Cell Lines by Antibody against Epidermal Growth Factor Receptor Promoting Formation of ErbB2/ErbB3 Heterodimers

  2007cites this paper
• Increased expression of pAKT is associated with radiation resistance in cervical cancer

  2006cites this paper
• CHAPTER 15 – Regulation of Gastrointestinal Normal Cell Growth

  2006cites this paper
• ErbB3-dependent motility and intravasation in breast cancer metastasis.

  2006cites this paper
• Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer.

  2006cites this paper
• Neuregulin regulates the formation of radial glial scaffold in hippocampal dentate gyrus of postnatal rats

  2006cites this paper
• Loss of Nrdp 1 Enhances ErbB 2 / ErbB 3 – Dependent Breast Tumor Cell Growth

  2006cites this paper
• Cyclic AMP synergistically enhances neuregulin‐dependent ERK and Akt activation and cell cycle progression in Schwann cells

  2006cites this paper
• Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

  2006cites this paper
• Interrelationships and clinical significance of expression of immunological markers in invasive breast carcinoma

  2006cites this paper
• Essential Role for Rac in Heregulin β1 Mitogenic Signaling: a Mechanism That Involves Epidermal Growth Factor Receptor and Is Independent of ErbB4

  2006cites this paper
• Tyrosine phosphorylation of PYK2 mediates heregulin‐induced glioma invasion: Novel heregulin/HER3‐stimulated signaling pathway in glioma

  2005cites this paper
• Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549

  2005cites this paper
• Roles for neuregulins in human cancer

  2005cites this paper
• Schwann cell behavior after nerve repair by means of tissue‐engineered muscle‐vein combined guides

  2005cites this paper
• Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.

  2005cites this paper
• Zinc Finger Transcription Factors Designed for Bispecific Coregulation of ErbB2 and ErbB3 Receptors: Insights into ErbB Receptor Biology

  2005cites this paper
• Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase.

  2005cites this paper
• Bi-directional Signaling between Gastrointestinal Peptide Hormone Receptors and Epidermal Growth Factor Receptor

  2004cites this paper
• Immunobiology of Her-2/Neu Transgenic Mice

  2004cites this paper
• ErbB4 Expression in Neural Progenitor Cells (ST14A) Is Necessary to Mediate Neuregulin-1β1-induced Migration*

  2004cites this paper
• Essential function for ErbB3 in breast cancer proliferation

  2004cites this paper
• Her-2/Neu as a Paradigm of a Tumor-Specific Target for Therapy

  2004cites this paper